Has Bradley Thomas, MD received payments from drug or device companies?

Yes. Drug and device makers reported $517,791 in general payments to Bradley Thomas, MD across 64 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bradley Thomas, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bradley Thomas, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bradley Thomas, MD

Sports Medicine · Manhattan Beach, CANPI 1093822363

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $456,445 of the $517,791 with a category attached, or 88.2%. Anika Therapeutics, Inc. accounts for 99.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2020 at $456,671 and has fallen 99.9% since, to $361 in 2025. Among sports medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$517,791in general payments, 2019–2025

Across 64 payments — averaging $8090.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Anika Therapeutics, Inc.$516K
Bioventus LLC$326
Johnson & Johnson$230
Stryker$218
Zimmer Biomet$202
Amgen$147
plus $465 from 13 others

$10,000in research payments, 2019–2025

Across 1 payment — averaging $10,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Zimmer Biomet$10K

What the payments were for

Food & beverage$1,5890%
Ownership interest$456,44588%
Other$59,75812%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Anika Therapeutics, Inc.	4	$516,202
Bioventus LLC	10	$326
Johnson & Johnson	12	$230
Stryker	4	$218
Zimmer Biomet	6	$202
Amgen	10	$147
Smith+Nephew	2	$79
GE HealthCare	1	$61
Pacira Pharmaceuticals Incorporated	2	$49
Cumberland Pharmaceuticals, Inc.	2	$47
Globus Medical	1	$45
Linvatec Corporation	2	$39
Endo Pharmaceuticals Inc.	2	$38
Fidia Pharma USA Inc.	1	$23
Highridge Medical LLC	1	$20
Vericel Corporation	1	$18
Ferring Pharmaceuticals Inc.	1	$17
Sanofi-aventis U.S. LLC	1	$16
Boston Scientific	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Biowick$125
NEW PRODUCT DEVELOPMENT$124

How this compares

$517,791 in reported general payments places this provider in the 95th percentile of 662 sports medicine providers in California.

See all sports medicine providers in California →

Medicare billing

Part B allowed, 2024

$442,295

Medicare patients

886

Services billed

10,330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ibuprofen	116	$968
Acetaminophen-CodeineAcetaminophen With Codeine	19	$287
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	33	$286
Meloxicam	46	$180
Famotidine	16	$149
Gabapentin	21	$99
Tramadol Hcl	12	$21

Paid to pharmacies, not to this prescriber.

Other sports medicine in Manhattan Beach

Neal ElattracheLos Angeles$51M
Nathaniel CohenLos Gatos$6.4M
Thomas KnappSanta Monica$2.5M
Michael FreehillStanford$1.6M
Allan MishraMenlo Park$1.5M
Heinz Hoeneckela Jolla$1.4M
Seth ShermanStanford$1.1M
Stephan YacoubianBurbank$1M
Stephen Snydervan Nuys$922K
Deryk JonesSan Carlos$915K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →